Residual Gastric Area and Weight Loss After Sleeve Gastrectomy
Relationship Between Residual Gastric Area and Weight Loss After Sleeve Gastrectomy: a Cohort Study
1 other identifier
observational
56
1 country
2
Brief Summary
BACKGROUND: The aim of this study is to evaluate the impact of the actual size and area of the remnant stomach, as measured by Upper gastrointestinal tract radiography, on weight loss after LSG. MATERIALS AND METHODS: From May 2017 to December 2019, 56 patients with morbid obesity were admitted to the Department of Medical and Surgical Sciences, University of Foggia and underwent laparoscopic sleeve gastrectomy. UGI tract radiography was performed on day two after the operation to rule out leakage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2017
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2021
CompletedFirst Submitted
Initial submission to the registry
November 15, 2021
CompletedFirst Posted
Study publicly available on registry
December 9, 2021
CompletedDecember 9, 2021
November 1, 2021
3.4 years
November 15, 2021
November 25, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative EWL % correlated with the Residual Stomach Area
the impact of the actual size and area of the remnant stomach, as measured by Upper gastrointestinal tract radiography, on weight loss
2017-2019
Interventions
Upper gastrointestinal radiographie
Eligibility Criteria
56 patients underwent sleeve gastrectomy with a mean age of 43,5± 11 years of which 40 were female.
You may qualify if:
- Adult patients of both genders with morbid obesity defined as BMI\>40 kg/m2
- Adult patients of both genders with morbid obesity defined as BMI\>35 kg/m2 with at least one associated major comorbidity
You may not qualify if:
- Patients with secondary obesity due to endocrine and psychologic disorders
- Patients whit previous bariatric procedures
- Patients unwilling to comply with postoperative diet regimen and exercise program.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Giovanna Pavone
Foggia, 71122, Italy
Nicola Tartaglia
Foggia, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical doctor
Study Record Dates
First Submitted
November 15, 2021
First Posted
December 9, 2021
Study Start
July 1, 2017
Primary Completion
December 1, 2020
Study Completion
July 1, 2021
Last Updated
December 9, 2021
Record last verified: 2021-11